Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05656963
What this trial is testing

The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD

Who this might be right for
Glomerulonephritis, MembranousDiabetic NephropathiesThrombelastography+1 more
Yipeng Liu 741
Not applicableUnknownNCT04534647
What this trial is testing

Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort

Who this might be right for
Lupus Nephritis
Liga Panamericana de Asociaciones de Reumatologia (PANLAR) 100
Not applicableNot Yet RecruitingNCT07598448
What this trial is testing

Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain

Who this might be right for
Complement 3 Glomerulopathy
Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)Looking for participantsNCT03673748
What this trial is testing

Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells

Who this might be right for
Lupus NephritisLupus Erythematosus
Red de Terapia Celular 20
Testing effectiveness (Phase 2)Looking for participantsNCT07522099
What this trial is testing

Chinese Adults With Kidney Disease

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)Complement 3 Glomerulopathy (C3G)IC-MPGN
ADARx Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00774852
What this trial is testing

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Erythematosus, Systemic
National Institute of Allergy and Infectious Diseases (NIAID) 137
Testing effectiveness (Phase 2)WithdrawnNCT02605525
What this trial is testing

Efficacy and Safety of SM101 in the Treatment of IgA Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Baxalta now part of Shire
Early research (Phase 1)Study completedNCT00818948
What this trial is testing

Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis

Who this might be right for
NephritisSystemic Lupus Erythematosus
Amgen 56
Not applicableStudy completedNCT00521508
What this trial is testing

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Centre Hospitalier Universitaire de Saint Etienne 45
Not applicableUnknownNCT06157125
What this trial is testing

Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN

Who this might be right for
Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
Assiut University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07541287
What this trial is testing

JADE101 in Participants With Immunoglobulin A Nephropathy

Who this might be right for
IgA Nephropathy
Jade Biosciences, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02112838
What this trial is testing

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy

Who this might be right for
IGA Nephropathy
Rigel Pharmaceuticals 76
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+6 more
Nanjing Bioheng Biotech Co., Ltd. 96
Testing effectiveness (Phase 2)Looking for participantsNCT07146906
What this trial is testing

Assess the Effects of Zigakibart on IgA Nephropathy.

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals 32
Not applicableLooking for participantsNCT06682507
What this trial is testing

High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)

Who this might be right for
Lupus Nephritis (LN)
First Affiliated Hospital, Sun Yat-Sen University 5,000
Large-scale testing (Phase 3)Study completedNCT00268567
What this trial is testing

Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

Who this might be right for
Nephritis, Lupus
Peking University
Not applicableUnknownNCT03549663
What this trial is testing

Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)

Who this might be right for
Idiopathic Membranous Nephropathy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 108
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Not applicableLooking for participantsNCT06654596
What this trial is testing

Efficacy and Safety of Telitacicept in IgAN

Who this might be right for
IgA Nephropathy (IgAN)Kidney DiseasesTelitacicept+1 more
Ruijin Hospital 118
Large-scale testing (Phase 3)Active Not RecruitingNCT04716231
What this trial is testing

Atacicept in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyBerger Disease
Vera Therapeutics, Inc. 376
Next Page